positive
Recently
Rubicon Research to list on exchanges tomorrow after massive oversubscription
Rubicon Research IPO lists tomorrow after >100× subscription, debut expected strong; proceeds to fund growth and debt reduction.
Pharmaceutical company Rubicon Research is set to list its shares on the BSE and NSE tomorrow, October 16, 2025, after closing a highly oversubscribed IPO that attracted bids more than 100×. The offering was fully allotted, and share credits are expected to be credited before debut. Proceeds will support debt repayment and expansion. Market sentiment is positive based on grey-market premium and institutional demand. Trading begins on the mainboard tomorrow morning.